Here's Why You Should Retain QuidelOrtho (QDEL) Stock for Now
https://www.zacks.com/stock/news/2199972/here-s-why-you-should-retain-quidelortho-qdel-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2199972
Dec 19, 2023 - QuidelOrtho's (QDEL) strong product portfolio raises optimism about the stock.
0
Reasons to Add DexCom (DXCM) Stock to Your Portfolio Now
https://www.zacks.com/stock/news/2199515/reasons-to-add-dexcom-dxcm-stock-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2199515
Dec 18, 2023 - DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
0
Here's Why Investors Should Hold Elevance (ELV) Stock for Now
https://www.zacks.com/stock/news/2198071/here-s-why-investors-should-hold-elevance-elv-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2198071
Dec 14, 2023 - Elevance's (ELV) Carelon unit will see growth due to improving performance in post-acute care services and Behavioral Health business.
0
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
https://www.zacks.com/stock/news/2197789/here-s-why-you-should-retain-glaukos-gkos-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197789
Dec 14, 2023 - Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
0
Centene (CNC) Unveils its 2024 Projections: Key Takeaways
https://www.zacks.com/stock/news/2197185/centene-cnc-unveils-its-2024-projections-key-takeaways?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2197185
Dec 13, 2023 - Centene's (CNC) board boosts its share buyback program with a new $4 billion fund.
0
Here's Why You Should Retain McKesson (MCK) Stock for Now
https://www.zacks.com/stock/news/2197165/here-s-why-you-should-retain-mckesson-mck-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197165
Dec 13, 2023 - McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
0
Reasons to Add Cardinal Health (CAH) to Your Portfolio Now
https://www.zacks.com/stock/news/2196582/reasons-to-add-cardinal-health-cah-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2196582
Dec 12, 2023 - Cardinal Health (CAH) continues to gain traction from a solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
0
HealthEquity, Inc. (HQY) Q3 2024 Earnings Call Transcript
https://seekingalpha.com/article/4656211-healthequity-inc-hqy-q3-2024-earnings-call-transcript?source=feed_sector_transcripts
Dec 05, 2023 - HealthEquity, Inc. (NASDAQ:NASDAQ:HQY) Q3 2024 Earnings Conference Call December 5, 2023 4:30 PM ETCompany ParticipantsRichard Putnam - Investor...
0
HealthEquity (HQY) Reports Q3 Earnings: What Key Metrics Have to Say
https://www.zacks.com/stock/news/2193838/healthequity-hqy-reports-q3-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2193838
Dec 05, 2023 - While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended October 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0